Alaska Permanent Fund Corp 13D and 13G filings for Vir Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 07:08 am Sale |
2020-12-31 | 13G | Vir Biotechnology, Inc. VIR |
Alaska Permanent Fund Corp | 3,893,040 3.060% |
-1,662,516 (-29.93%) |
Filing |